These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27629732)

  • 1. Adiponectin and Cardiac Hypertrophy in Acromegaly.
    Gurbulak S; Akin F; Yerlikaya E; Yaylali GF; Topsakal S; Tanriverdi H; Akdag B; Kaptanoglu B
    Adv Clin Exp Med; 2016; 25(3):449-55. PubMed ID: 27629732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance.
    Silha JV; Krsek M; Hana V; Marek J; Jezkova J; Weiss V; Murphy LJ
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):736-42. PubMed ID: 12780751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral adiposity index is associated with insulin sensitivity and adipocytokine levels in newly diagnosed acromegalic patients.
    Ciresi A; Amato MC; Pizzolanti G; Giordano Galluzzo C
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2907-15. PubMed ID: 22679062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum adiponectin levels in patients with acromegaly].
    Siemińska L; Lenart J; Cichoń-Lenart A; Niedziołka D; Marek B; Kos-Kudła B; Kajdaniuk D; Nowak M
    Pol Merkur Lekarski; 2005 Oct; 19(112):514-6. PubMed ID: 16379314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess.
    Lam KS; Xu A; Tan KC; Wong LC; Tiu SC; Tam S
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5448-53. PubMed ID: 15531496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum adiponectin levels in adult growth hormone deficiency and acromegaly.
    Fukuda I; Hizuka N; Ishikawa Y; Itoh E; Yasumoto K; Murakami Y; Sata A; Tsukada J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2004 Dec; 14(6):449-54. PubMed ID: 15519253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
    Colao A; Baldelli R; Marzullo P; Ferretti E; Ferone D; Gargiulo P; Petretta M; Tamburrano G; Lombardi G; Liuzzi A
    J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any relation between hyperinsulinemia, insulin resistance and colorectal lesions in patients with acromegaly?
    Foltyn W; Kos-Kudla B; Strzelczyk J; Matyja V; Karpe J; Rudnik A; Marek B; Kajdaniuk D; Sieron A; Latos W
    Neuro Endocrinol Lett; 2008 Feb; 29(1):107-12. PubMed ID: 18283256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating adiponectin levels and cardiovascular risk factors in acromegalic patients.
    Ronchi CL; Corbetta S; Cappiello V; Morpurgo PS; Giavoli C; Beck-Peccoz P; Arosio M; Spada A
    Eur J Endocrinol; 2004 May; 150(5):663-9. PubMed ID: 15132722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistin and leptin levels in acromegaly: lack of correlation with echocardiographic findings.
    Gurbulak S; Yaylali GF; Yerlikaya E; Akin F; Topsakal S; Tanrverdi H; Akdag B; Aslan AR
    J Investig Med; 2013 Mar; 61(3):582-5. PubMed ID: 23360845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac effect of thyrotoxicosis in acromegaly.
    Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
    Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered circadian blood pressure profile in patients with active acromegaly. Relationship with left ventricular mass and hormonal values.
    Pietrobelli DJ; Akopian M; Olivieri AO; Renauld A; Garrido D; Artese R; Feldstein CA
    J Hum Hypertens; 2001 Sep; 15(9):601-5. PubMed ID: 11550105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
    Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
    J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
    Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
    Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
    Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.